Mary Kay Inc. Advocates for Women’s Empowerment, Safe and Dignified Work Environments at International Women’s Forum – TIME’S UP UK Virtual Event
22.7.2020 15:00:00 EEST | Business Wire | Press release
On May 21st, Mary Kay Inc., an advocate for global women’s empowerment and entrepreneurship, joined the International Women's Forum (IWF) Virtual Conference, for a session titled “SAFE SETS: An online panel discussion with TIME’S UP UK.”
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005187/en/
Carolyn Passey, General Manager, Mary Kay United Kingdom & Ireland (Photo: Mary Kay Inc.)
The live session tackled the ever-present issue for women across the globe: sexual harassment and abuse in the workplace. TIME’S UP UK stressed the critical importance of changing the culture to ensure a safe workplace free from harassment and referred to the work being done to define safety for women in film through intimacy guidelines.
The speakers with TIME’S UP UK included:
- Dame Heather Rabbatts, TIME’S UP UK Chair, Managing Director of Cove Pictures; Chair of Soho Theatre and non-executive board member for Arts Alliance.
- Ita O’Brien, the UK’s leading Intimacy Coordinator and founder of Intimacy on Set, her company through which she has been developing best practices regarding intimacy and nudity in film, television and theatre and through which she trains Intimacy Coordinators all over the world.
“TIME’S UP’s efforts will help bring about broader change for women in the workplace – worldwide and across industries,” said Carolyn Passey, General Manager of Mary Kay UK and Ireland. “As one of the world’s leading champions of women’s empowerment, Mary Kay is proud to support, through IWF, women leaders who are standing up to give fellow women a voice, help them embrace their identity and define their own boundaries.”
“What was increasingly apparent throughout the conversation was how #MeToo and TIME’S UP have had a huge and positive influence for changing the way productions work, how they are shifting to better practices in many new ways, and in particular with the new role of the Intimacy Coordinator,” said Dame Heather Rabbatts. “The conversation about safe sets is about how we make the culture shift, one industry after another, until we don’t need to have this conversation ever again.”
“‘Yes’, means yes, ‘no’ means no, and ‘maybe’ means no – we celebrate and embrace the ‘no’,” emphasized Ita O’Brien, when talking of the process during which actors get to voice their comfort level when shooting intimate scenes. The firm founded by O’Brien, Intimacy on Set, has put in place guidelines to provide clear lanes of communication and consent not only between actors, but also everyone else involved in shooting intimate and emotional scenes. “Clear boundaries actually create freedom and help understand what is right for you.”
“This line goes to the heart of the matter, and how we are all learning to express where our boundaries lie, and not being afraid to share them,” concluded Dame Heather Rabbatts. “Having in place some mechanisms to protect yourself is very important, so that we know we can exercise a ‘no’. This should empower us in all the sticky and difficult situations that happen in life, whether personal or professional.”
“It is invigorating to witness the influential work that female thought leaders and advocates have achieved over the past several years for the advancement of women’s safety and security in the workplace. These women, some of the most influential thought leaders in the United Kingdom, are on a mission to champion the next generation of women to become tomorrow’s leaders,” said Marty Wikstrom, Member of IWF U.K. and co-chair of the Cornerstone Conference. “IWF has been advancing women’s leadership and championing equality worldwide since 1974, and Mary Kay has been an advocate of women’s entrepreneurship and leadership since 1963. This session reflects a meeting of the minds, and we are proud to showcase this female-fueled partnership.”
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com.
About International Women’s Forum (IWF) and the Leadership Foundation
IWF is an invitation-only membership organization of more than 7,000 diverse and accomplished women from 33 nations on six continents. IWF advances women’s leadership and champions equality worldwide by connecting accomplished women both globally and locally. Members include Fortune 500 executives, government leaders from the local to sovereign level, international nonprofit leaders, and luminaries from the academy, arts and sciences: www.iwforum.org.
About TIME’S UP UK
TIME’S UP is an organisation that insists on safe, fair and dignified work for women of all kinds. In response to the growing TIME’S UP movement in the US, a group of UK-based women: actors, producers, writers and others from the film, TV and theatre industries catalysed a sister initiative in the UK. For maximum impact it is set up under the TIME’S UP brand and aims to amplify and reinforce the message already promoted in the US.
The UK movement seeks to build on key elements of the solidarity letter released by TIME’S UP and the statement by the activists attending the Globes, which emphasised the need to highlight the connections between the harassment revelations in Hollywood and the wider, systematic nature of harassment and violence against women across all industries, contexts and countries with the recognition that this issue is universal. We seek strength in unity and maximum cooperation. The activist statement also flagged the ways in which the TIME’S UP initiative joins an ever-growing collective of organisations, movements and leaders working to end gender-based violence. The UK work stands absolutely in solidarity with existing movements: TIME’S UP UK is also now a recently formed charity, and as a charity we can only continue the work with support and donations. We all appreciate that we are experiencing unprecedented challenges but as TIME’S UP focusses on safety for all women in the workplace, which now includes the home, we hope you will be able to support us: www.timesupuk.org.
About Intimacy on Set
Founded in 2018, Intimacy on Set provides services to TV, film, & theatre when dealing with intimacy, sexual content, and nudity. Its Founder, UK’s leading Intimacy Coordinator, Ita O’Brien, pioneered the role of the Intimacy Coordinator and since 2014 has been developing best practice Intimacy on Set Guidelines, which have been widely adopted in the industry. Championed by the TIME’S UP movement and others, the firm advocates for safe, fair and dignified work for everyone. O’Brien has worked on numerous high profile productions including Normal People (BBC3/Hulu), Sex Education 1&2 (Netflix), Gangs of London (Sky Atlantic), The Great (Hulu) and I May Destroy You (BBC/HBO), and has been widely covered in the national and international media as the leading spokesperson in this space: www.intimacyonset.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200722005187/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
